Accelerate Diagnostics (AXDX) Reports Q3 Loss, Misses Revenue Estimates

7 Nov 2019 - Yahoo News
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 5.13% and -27.97%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
usx:axdx

---

Accelerate Diagnostics Reports Third Quarter 2019 Financial Results

7 Nov 2019 - Yahoo News
TUCSON, Ariz. , Nov. 7, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the third quarter ended September 30, 2019 . "Our placement and revenue ...
usx:axdx

---

Will Accelerate Diagnostics (AXDX) Report Negative Earnings Next Week? What You Should Know

31 Oct 2019 - Yahoo News
Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
usx:axdx

---

Is Accelerate Diagnostics Inc (AXDX) Going To Burn These Hedge Funds ?

28 Oct 2019 - Yahoo News
The elite funds run by legendary investors such as David Tepper and Dan Loeb make hundreds of millions of dollars for themselves and their investors by spending enormous resources doing research on small cap stocks that big investment banks don't follow. Because of their pay structures, they have strong ...
usx:axdx

---

Accelerate Diagnostics Schedules Call to Review Third Quarter 2019 Results

17 Oct 2019 - Yahoo News
TUCSON, Ariz. , Oct. 17, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that it will report financial results for the third quarter of 2019 after the market close on Thursday, ...
usx:axdx

---

Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes

3 Oct 2019 - Yahoo News
"We are thrilled to see these data, which demonstrate conclusively that the Accelerate PhenoTest™ BC kit positively impacts clinical outcomes across a diverse set of institutions and patient populations. The first of the studies is RAPIDS-GN (ClinicalTrials.gov # NCT03218397), a randomized controlled ...
usx:axdx

---

Accelerate Diagnostics Highlights Clinical Endpoints Achieved Across Mayo Clinic/UCLA, University of Iowa, and UAMS Studies

18 Sep 2019 - Yahoo News
TUCSON, Ariz., Sept. 18, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. (AXDX) today announced the release of positive results from three clinical studies on the Accelerate Pheno™ system that will be presented at IDWeek™ 2019. The first of these studies is the ARLG-sponsored RAPIDS-GN clinical study ...
usx:axdx

---

Accelerate Diagnostics (AXDX) Q2 2019 Earnings Call Transcript

9 Aug 2019 - Nasdaq
Image source The Motley Fool Accelerate Diagnostics NASDAQ AXDX Q2 160 2019 Earnings Call Aug 08 2019 4 30 p m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks Operator
usx:axdx

---

Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

9 Aug 2019 - Nasdaq
Accelerate Diagnostics AXDX came out with a quarterly loss of 0 38 per share versus the Zacks Consensus Estimate of a loss of 0 40 This compares to loss of 0 43 per share a year ago These figures are adjusted for non recurring items This quarterly report represents an earnings surprise
usx:axdx

---

Accelerate Diagnostics (AXDX) Q2 2019 Earnings Call Transcript

9 Aug 2019 - Yahoo News
AXDX earnings call for the period ending June 30, 2019.
usx:axdx

---